TTrialPathMatch Me to Trials
← Back to trials
RecruitingGlioblastoma (GBM)

Music Therapy in Newly Diagnosed Glioblastoma After Chemoradiation Therapy (MELODY-GBM)

Eligible age

18+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The Brain Cancer Program, in partnership with the Center for Music and Medicine at Johns Hopkins, will study whether music therapy is feasible in newly diagnosed GBM patients undergoing standard care.

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

You may qualify if…

  • ✓ Glioblastoma (Newly Diagnosed)
  • ✓ Cognitive capacity to respond to surveys
  • ✓ Access to computer and web access
  • ✓ Ability to attend virtual music therapy sessions
  • ✓ Audibly process music
  • ✓ Proficient in English

You may not qualify if…

  • ✕ Not planning to undergo standard of care radiation therapy and concurrent and adjuvant temozolomide.
  • ✕ A life expectancy of less than 6 months.
  • ✕ Concurrent use of any other standard or investigational agents (excepting tumor treating fields).
  • ✕ Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection or psychiatric illness/social situations that would limit adherence with study requirements.

Where it's recruiting

Maryland

Baltimore

Source: ClinicalTrials.gov · NCT07375992 · last updated 2026-06-18

Music Therapy in Newly Diagnosed Glioblastoma After Chemoradiation The · TrialPath